Published price vs quote-only
Shed vs Maximus: Which One Publishes Its Price? (2026)
Shed quotes after intake vs Maximus $133/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.9 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
On paper, Shed and Maximus sell the same thing: a prescription, a vial and a delivery date. In practice they are priced and staffed on different assumptions.
A discount off an undisclosed number is not a price. Shed quotes after intake, while Maximus states $132.99/mo on the way in — which makes one of these two comparable in advance and the other not.
Rather than restate two feature lists, this compares the two on cost over time, medication access, price stability and the support each one includes. Where a figure is not published, that is stated rather than estimated.
The short answer
- Easier to price in advance
- Maximus — $132.99/mo. The other side quotes after intake, so a like-for-like total is not available before you apply.
- FDA-approved medication
- Shed — The only side that can write an approved brand-name product at all — it offers name-brand FDA-approved GLP-1 and compounded GLP-1.
- Least friction to get going
- Maximus — Telemedicine intake, no clinic visits, then home delivery.
- Longest public track record
- Shed — 8,500 patient reviews against 2,896.
The short version: Shed vs Maximus
Two programs, side by side, on their own published terms — with the rows that differ doing the work.
| Shed | Maximus | |
|---|---|---|
| Advertised price | 10% off the first month, price quoted after intake | $132.99/mo |
| Rate after promotions | not published before intake | $133/mo |
| Pricing structure | Quoted only after intake | Flat rate at every dose |
| Medication | Name-brand FDA-approved GLP-1 and compounded GLP-1 | Compounded semaglutide |
| Price transparency | Quote only, after intake | Published upfront |
| How fast you start | 2-minute approval assessment | Telemedicine intake, no clinic visits |
| Membership fee | Not stated | None |
| State coverage | Not published | Not published |
| Support model | Coaching built into the plan | No coaching program stated |
| Patient reviews | 8,500 | 2,896 |
| eRxDoctor score | 9.9/10 | 7.0/10 |
The real cost: six months and twelve
A first-month price is a customer-acquisition number. The totals below are the honest version, built from the rates each provider publishes.
| Shed | Maximus | |
|---|---|---|
| First month | Not published | $133 |
| Months 2 onward | Not published | $133/mo |
| 6-month total | Not computable | $798 |
| 12-month total | Not computable | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
A like-for-like annual total is not available for Shed: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Treat any comparison that quotes one as an estimate someone else has made for you.
What you know before you hand over a medical history
With Maximus the arithmetic is available in advance — $132.99/mo, on flat rate at every dose terms — so it can be compared against anything else on the market.
Shed inverts that: Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. Personalization is a real justification, but the result is a quote delivered at the point you have already invested time in the process.
If you do go through Shed's intake, ask for the month-two price in writing before you pay for month one. That single question resolves most of the disclosure gap.
Shed in detail
Shed offers both name-brand and compounded GLP-1 weight loss medications with integrated coaching, a 2-minute approval assessment, and 10% off your first month. In this pairing, its distinguishing feature is one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it.
Intake is 2-minute approval assessment. Fulfillment is home delivery after clinician review. The commercial terms are quoted only after intake, quote only, after intake.
Behind the prescription sits continuous coaching built into every treatment plan. Available medication: name-brand FDA-approved GLP-1 and compounded GLP-1.
Shed pros
- 10% off your first month for new patients
- Fast 2-minute approval assessment
- Continuous coaching is integrated into treatment, not just a prescription
- Offers both FDA-approved name-brand GLP-1 and compounded options on one platform
Shed cons
- Name-brand options carry significantly higher costs than compounded alternatives
- Standard pricing is not published, you receive a personalized quote after intake
- Coaching-bundled model can cost more than bare-prescription platforms
Read next to Maximus, the weak point: you cannot know what you will pay until you have finished the intake.
A closer look at Maximus
$132.99 per Month What it is really selling here is a low flat rate with a simple direct-pay structure and nothing bolted on.
Getting started means telemedicine intake, no clinic visits, after which home delivery. Pricing runs on a flat rate at every dose basis, published upfront.
Ongoing care is prescriptions approved by licensed doctors, filled through U.S. pharmacies, and the medication list runs to compounded semaglutide.
Maximus pros
- Prescriptions approved by licensed doctors
- Medication filled through trusted U.S. pharmacies
- Low flat rate at $132.99/month
- Convenient telemedicine access with no clinic visits
Maximus cons
- No published outcome or weight loss guarantee
- Limited published detail on tirzepatide availability and program features
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
Where it gives ground to Shed: the smallest patient base here, with limited published detail on tirzepatide.
Who should choose Shed, and who should choose Maximus
Choose Shed if:
- delivery works the way you want it to: home delivery after clinician review
- you want to start on their timeline: 2-minute approval assessment
- the level of clinical contact suits you: continuous coaching built into every treatment plan
- the feature you would actually use: one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it
Choose Maximus if:
- you want the full price in front of you before completing an intake
- you want the price you sign up at to survive titration
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
- you would get real value from a low flat rate with a simple direct-pay structure and nothing bolted on
The compromises on both sides
On price. Only Maximus publishes a rate you can plan against ($132.99/mo). The other quotes after intake, which is a cost of a different kind: you cannot budget the year in advance.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On medication. Shed covers name-brand FDA-approved GLP-1 and compounded GLP-1; Maximus covers compounded semaglutide. Neither locks you out of a molecule the other offers, so this is unlikely to be the deciding factor.
On clinical contact. The support models differ — continuous coaching built into every treatment plan against prescriptions approved by licensed doctors, filled through U.S. pharmacies — and that difference is felt in week two, not week one.
What the evidence actually says
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
NIDDK frames medication as one component of obesity treatment rather than a replacement for the rest of it, per NIH, NIDDK.
Use it as the floor for the conversation with whichever prescriber you end up with, rather than as a reason to pick one platform over the other.
Shed vs Maximus: common questions
How much does Shed cost?
Shed does not publish standard pricing; you receive a personalized quote after completing the intake assessment. That is the honest answer, and it is the main practical drawback next to Maximus, which publishes $132.99/mo upfront. If you go through the intake, ask for the month-two and maintenance-dose prices in writing before paying for the first month.
Which is cheaper to start, Shed or Maximus?
Only Maximus publishes a first-month figure ($132.99/mo). The other quotes after intake, so a starting-cost comparison is not available in advance.
How fast can I start with Shed compared with Maximus?
Shed advertises 2-minute approval assessment, with home delivery after clinician review. Maximus advertises telemedicine intake, no clinic visits, with home delivery. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Is coaching included with Shed or Maximus?
Shed includes continuous coaching built into every treatment plan in the monthly price. Maximus provides prescriptions approved by licensed doctors, filled through U.S. pharmacies, without a separate coaching program. If medication alone has failed you before, the bundled version is the one to price properly rather than the one to cut.
Are Shed and Maximus legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Shed operates on quoted only after intake with pricing quote only, after intake, Maximus on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
Is Shed or Maximus better for a first GLP-1 prescription?
For a first prescription, weight support over price. Shed offers more contact (continuous coaching built into every treatment plan), which matters most in the first eight weeks when side effects and titration questions are at their peak. Once you know how you tolerate the medication, the cheaper program becomes the rational choice.
The verdict
Neither of these two publishes enough for a clean cost verdict, which is itself the finding. Shed leads on one of the few platforms that will write either a name-brand or a compounded GLP-1, with coaching bundled into the plan rather than sold beside it; Maximus leads on a low flat rate with a simple direct-pay structure and nothing bolted on.
Before choosing either, get the maintenance-dose price in writing. Without it, any comparison — including this one — is working with half the information.
Both platforms are legitimate routes to a GLP-1 prescription. The decision is commercial, and it should be made with the twelve-month figure in front of you rather than the first-month one.
Keep comparing
- Shed vs Mochi HealthPublished price vs quote-only
- Shed vs Elevate HealthPublished price vs quote-only
- Measured vs MaximusCoaching-supported vs medication-only
- Directmeds vs MaximusPublished price vs quote-only
- JoinFridays vs WellorithmPublished price vs quote-only
- JoinFridays vs Start WillowPublished price vs quote-only
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Shed or Maximus, and does not sell treatment. Read our ranking methodology.